Atlas Trials

Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension

Clinical trial NCT04927299 · COMPLETED

Trial details

NCT number
NCT04927299
Sponsor
Laboratorios Silanes S.A. de C.V.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Essential Arterial Hypertension
Start date
2022-06-30
Primary completion
2023-08-15
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.